Honeywell has introduced a new liquid flow sensing platform designed and developed to increase the accuracy of dosing liquid medications and improve the treatment process for patients.
Lonza has announced an expansion of its service offering for orally delivered biologic therapies to support the unique development and manufacturing needs of smart capsules companies.
Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetics industries, is expanding its production capacity in Skopje, North Macedonia, with a new production hall for syringes.
Editor Rebekah Jordan spoke to Honeywell to explore its long-term supply agreement with DevPro Biopharma to develop a respiratory inhaler that enhances the well-being of patients.
Alex Fong, insights and sustainability lead, Owen Mumford, addresses the environmental impact of single-use drug delivery devices and emphasises the role of life-cycle assessment (LCA) in sustainable design.
Given the success of nasal drug-delivery products relies on balancing formulation and device selection, Eric Kaneps at Renaissance Lakewood, LLC explains the importance of partnerships and collaborations drug development and manufacturing.
Aptamer Group announced that a genetic medicines customer has selected to progress to the final commercial development phase for Optimer delivery vehicles.
Bespak and Orbia Advance Corporation announced a collaboration intended to accelerate the transition to climate-friendly inhalers utilising Orbia Fluor & Energy Materials’ low global warming potential propellant known as Zephex 152a.
SGS technicians at the Wavre laboratory have paired the Malvern Spraytec system with the Mighty Runt actuator to precisely assess how factors like device actuation – including pump velocity and force – and droplet size impact drug delivery.
Berry Global has launched a new easy-squeeze ophthalmic 10ml bottle that has been qualified for use with Aptar Pharma’s globally recognised Ophthalmic Squeeze Dispenser (OSD).
ApiJect announced it has been awarded an initial grant of $425,000 from the Bill & Melinda Gates Foundation to develop low-cost blow-fill-seal prefilled injection devices to enhance access in Low- and Middle-Income Countries (LMICs).
